The global malaria vaccine market is expected to exhibit a CAGR of around 34% during 2022-2030.
Malaria refers to a disease caused by the plasmodium parasite which is transmitted to the human body from the bite of infected mosquitoes. Malaria vaccine refers to a biological component that stimulates the production of antibodies to mitigate the risk of contracting malaria. Some common symptoms of malaria include fever, fatigue, nausea, headaches, chills, etc. Malaria vaccines can be administered in several ways, including intramuscular, subcutaneous, and intradermal injections. These vaccines can be widely categorized into pre-erythrocytic vaccine, erythrocytic vaccine, and multi-antigen vaccine.
The increasing prevalence of malaria, particularly across tropical countries, is primarily driving the global malaria vaccine market. Additionally, several government and non-government organizations are launching favorable initiatives to spread awareness regarding disease prevention as well as the importance of immunization among the masses, especially in the endemic and rural regions. This, in turn, is creating a positive outlook for the market. Furthermore, the introduction of pre-erythrocytic vaccines, commonly known as anti-infective vaccines, that target the plasmodium parasite and prevent progression to chronic blood-stage diseases is also augmenting the market growth. Apart from this, several pharmaceutical companies are focusing on the development of new and improved malaria vaccines by accelerating the clinical trials of various pipeline drugs. Moreover, continuous technological advancements, including the advent of novel adjuvants and cutting-edge vaccine delivery platforms, are expected to drive the global malaria vaccine market in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global malaria vaccine market report, along with forecasts at the global, and regional level from 2022-2030. Our report has categorized the market based on type, agent, route of administration and distribution channel.
Breakup by Type:
Breakup by Agent:
Breakup by Route of Administration:
Breakup by Distribution Channel:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Report Features | Details |
---|---|
Base Year of the Analysis | 2022 |
Forecast Period | 2022-2030 |
Units | Million Doses |
Segment Coverage | Type, Agent, Route of Administration, Distribution Channel, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Customization Scope | 10% Free Customization |
Report Price and Purchase Option | Single User License: US$ 2499 Five User License: US$ 3499 Corporate License: US$ 4499 |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |